October 16, 2017 7:00pm

What’s as valuable as clinical results?  In this market, the credibility and authenticity of the management team backing their words with action, not always perfect yet adaptive through time, news events in development stages

 

How many times, do I have to say it; confidence enables momentum and ultimately pricing

 

Out and about: Athersys (ATHX -$ 0.07 or -3.23%) has agreed to settle its patent fight with Garnet Biotherapeutics and will pay Garnet $500K and issue it 1M shares of common stock plus $250K in each of the next four quarters … Funny how this issue never hit the news until after a substantial payment?

Pre-open indications: 3 hit and 0 miss

 

In the grip of rotating cycles and disparaging trends, what is the price of sector equities - knowledge and a subscription!  


Members only. Please login.